Control of Prion Uptake by Bone Morphogenetic Protein Signaling
Preprint
Abstract
Prions propagate through cycles of intracellular replication, release, and uptake by host cells. Each of these steps is required for disease progression. Here, we used dCAS9-VP64 mediated transactivation to screen for determinants of prion uptake. We transduced PRNP -/- SH-SY5Y cells with a post-pooled human quadruple-guide-RNA library targeting all transcription start sites of the protein-coding genome, exposed them to synthetic infectious prions, and identified modifiers of prion internalization. Specificity was tested by counterscreens with other neurodegeneration-related aggregates and endocytic probes. Surprisingly, the Bone Morphogenetic Protein (BMP) signaling pathway emerged as a strong modulator. Prion uptake was increased by transcriptional activation of the BMPR1B, BMPR2 and ACVRL1 receptors, by the BMP effector SMAD1 and by exposure to BMP ligands. Conversely, prion uptake was reduced by activation of the BMP inhibitor SMAD6. Pharmacological inhibition of BMP signaling by the antagonistic ligand noggin and by the BMP kinase inhibitor dorsomorphin decreased prion internalization, reduced the number of prion-carrying cells, and suppressed the accumulation of proteinase-resistant prion protein in a panel of chronically infected human cell lines. Hence, cell-autonomous and non-autonomous BMP signaling components regulate prion uptake, and their manipulation provides a framework for interfering with the early steps of prion propagation.Keywords
Funding Information
- Universität Zürich (FK-20-046)
- Parkinson Schweiz
- Uniscientia (241 -2025)
- Foundation for Research in Science and the Humanities (STWF-24-11)
- Innovation Fund of the University Hospital Zurich (INOV00169)
- Fondazione Gelu
- Human Frontiers Science Program (RGP0001/2022)
- Uniscientia Foundation (241 -2025)
This publication has 95 references indexed in Scilit:
- Axon guidance at the spinal cord midline—A live imaging perspectiveJournal of Comparative Neurology, 2021
- Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment2021
- PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteinsActa Neuropathologica, 2019
- Exosomes and their role in the intercellular trafficking of normal and disease associated prion proteinsMolecular Aspects of Medicine, 2018
- Cofactors influence the biological properties of infectious recombinant prionsActa Neuropathologica, 2017
- A CRISPR Approach to Neurodegenerative DiseasesTrends in Molecular Medicine, 2017
- Preparing Synthetic Aβ in Different Aggregation States2010
- Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopyEuropean Journal of Cell Biology, 2009
- Galectin‐3/MAC‐2, Ras and PI3K activate complement receptor‐3 and scavenger receptor‐AI/II mediated myelin phagocytosis in microgliaGlia, 2008
- An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous systemNeuron, 1991